MA45994A - Vaccins contre des virus - Google Patents
Vaccins contre des virusInfo
- Publication number
- MA45994A MA45994A MA045994A MA45994A MA45994A MA 45994 A MA45994 A MA 45994A MA 045994 A MA045994 A MA 045994A MA 45994 A MA45994 A MA 45994A MA 45994 A MA45994 A MA 45994A
- Authority
- MA
- Morocco
- Prior art keywords
- vaccines against
- against viruses
- viruses
- vaccines
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/76—Viruses; Subviral particles; Bacteriophages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/275—Poxviridae, e.g. avipoxvirus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5256—Virus expressing foreign proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/58—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
- C12N2710/24134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
- C12N2710/24141—Use of virus, viral particle or viral elements as a vector
- C12N2710/24143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
- C12N2770/24134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
- C12N2770/24141—Use of virus, viral particle or viral elements as a vector
- C12N2770/24143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/36011—Togaviridae
- C12N2770/36111—Alphavirus, e.g. Sindbis virus, VEE, EEE, WEE, Semliki
- C12N2770/36134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2016903295A AU2016903295A0 (en) | 2016-08-19 | Viral Vaccines |
Publications (1)
Publication Number | Publication Date |
---|---|
MA45994A true MA45994A (fr) | 2021-03-17 |
Family
ID=61195904
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA045994A MA45994A (fr) | 2016-08-19 | 2017-08-18 | Vaccins contre des virus |
Country Status (17)
Country | Link |
---|---|
US (2) | US10905759B2 (fr) |
EP (2) | EP3500280A4 (fr) |
JP (1) | JP2019528271A (fr) |
KR (1) | KR20190050787A (fr) |
CN (1) | CN109862909A (fr) |
AR (1) | AR110624A1 (fr) |
AU (1) | AU2017313450B2 (fr) |
BR (1) | BR112019003181A2 (fr) |
CA (1) | CA3034282A1 (fr) |
CL (1) | CL2019000405A1 (fr) |
IL (1) | IL264893B (fr) |
MA (1) | MA45994A (fr) |
MX (1) | MX2019001919A (fr) |
NZ (1) | NZ750578A (fr) |
SG (1) | SG11201900814QA (fr) |
TW (1) | TWI728173B (fr) |
WO (1) | WO2018032057A1 (fr) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20210299245A1 (en) * | 2020-03-31 | 2021-09-30 | Sementis Limited | Attenuated poxvirus vector based vaccine for protection against covid-19 |
CN112362877B (zh) * | 2020-10-27 | 2024-04-12 | 江苏先声医学诊断有限公司 | 一种mbp重组蛋白以及其应用 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995030018A2 (fr) * | 1994-04-29 | 1995-11-09 | Immuno Aktiengesellschaft | Poxvirus recombines dans des regions essentielles a l'aide de polynucleotides etrangers |
CN1418951A (zh) | 2001-05-23 | 2003-05-21 | 广州绿健生物技术有限公司 | 生产rna病毒和基于rna病毒的载体颗粒的组合物及方法 |
NZ536502A (en) * | 2002-05-16 | 2005-10-28 | Bavarian Nordic As | Recombinant poxvirus expressing homologous genes inserted into the poxviral genome for inducing an immune response in a mammal |
CN1754002B (zh) * | 2002-08-12 | 2010-09-08 | 杰能斯有限公司 | 涉及痘病毒和癌的组合物及制备方法 |
KR20040015624A (ko) | 2002-08-13 | 2004-02-19 | 대한뉴팜(주) | 플로르페니콜을 활성성분으로 함유하는 경구투여용약제학적 조성물 |
CN1723285B (zh) * | 2003-02-18 | 2013-01-02 | 德国慕尼黑亥姆霍兹研究中心健康和环境有限公司 | 重组的mva及其产生方法 |
EP1518932A1 (fr) * | 2003-09-29 | 2005-03-30 | GSF-Forschungszentrum für Umwelt und Gesundheit GmbH | Mutant du virus de la vaccine Ankara modifié (MVA) et utilisation correspondante |
EP1683870A1 (fr) * | 2005-01-24 | 2006-07-26 | GSF-Forschungszentrum für Umwelt und Gesundheit GmbH | Vaccins à base de l'utilisation de MVA |
GB201006405D0 (en) * | 2010-04-16 | 2010-06-02 | Isis Innovation | Poxvirus expression system |
CN103200962A (zh) * | 2010-09-23 | 2013-07-10 | 巴克斯特国际公司 | 重组病毒载体及用于诱导对黄热病毒的免疫反应的方法 |
KR102212253B1 (ko) | 2013-03-15 | 2021-02-04 | 세멘티스 리미티드 | 면역 조절 |
EP3063278B1 (fr) * | 2013-11-01 | 2018-02-28 | Sementis Limited | Production de vecteur viral |
WO2016086980A1 (fr) * | 2014-12-02 | 2016-06-09 | Consejo Superior De Investigaciones Cientificas | Composition de vaccin |
BR112018015696A2 (pt) | 2016-02-03 | 2018-12-26 | Geovax Inc | composições e métodos para gerar uma resposta imune para um flavivírus |
-
2017
- 2017-08-18 JP JP2019508842A patent/JP2019528271A/ja active Pending
- 2017-08-18 CA CA3034282A patent/CA3034282A1/fr active Pending
- 2017-08-18 KR KR1020197007662A patent/KR20190050787A/ko not_active Application Discontinuation
- 2017-08-18 IL IL264893A patent/IL264893B/en unknown
- 2017-08-18 AU AU2017313450A patent/AU2017313450B2/en active Active
- 2017-08-18 TW TW106128111A patent/TWI728173B/zh active
- 2017-08-18 NZ NZ750578A patent/NZ750578A/en unknown
- 2017-08-18 MX MX2019001919A patent/MX2019001919A/es unknown
- 2017-08-18 EP EP17840633.6A patent/EP3500280A4/fr active Pending
- 2017-08-18 WO PCT/AU2017/050879 patent/WO2018032057A1/fr active Search and Examination
- 2017-08-18 MA MA045994A patent/MA45994A/fr unknown
- 2017-08-18 EP EP23215911.1A patent/EP4331676A2/fr active Pending
- 2017-08-18 SG SG11201900814QA patent/SG11201900814QA/en unknown
- 2017-08-18 US US16/325,539 patent/US10905759B2/en active Active
- 2017-08-18 CN CN201780063830.0A patent/CN109862909A/zh active Pending
- 2017-08-18 AR ARP170102311A patent/AR110624A1/es unknown
- 2017-08-18 BR BR112019003181A patent/BR112019003181A2/pt active Search and Examination
-
2019
- 2019-02-14 CL CL2019000405A patent/CL2019000405A1/es unknown
-
2020
- 2020-12-22 US US17/130,165 patent/US20210113684A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AU2017313450B2 (en) | 2024-02-15 |
CL2019000405A1 (es) | 2019-06-14 |
MX2019001919A (es) | 2019-09-04 |
NZ750578A (en) | 2023-05-26 |
CA3034282A1 (fr) | 2018-02-22 |
US10905759B2 (en) | 2021-02-02 |
BR112019003181A2 (pt) | 2019-07-16 |
TWI728173B (zh) | 2021-05-21 |
US20200009245A1 (en) | 2020-01-09 |
SG11201900814QA (en) | 2019-03-28 |
AU2017313450A1 (en) | 2019-02-28 |
RU2019107582A3 (fr) | 2021-03-31 |
EP3500280A1 (fr) | 2019-06-26 |
RU2019107582A (ru) | 2020-09-21 |
EP3500280A4 (fr) | 2020-05-13 |
KR20190050787A (ko) | 2019-05-13 |
IL264893A (fr) | 2019-04-30 |
AR110624A1 (es) | 2019-04-17 |
WO2018032057A1 (fr) | 2018-02-22 |
JP2019528271A (ja) | 2019-10-10 |
US20210113684A1 (en) | 2021-04-22 |
IL264893B (en) | 2022-08-01 |
CN109862909A (zh) | 2019-06-07 |
EP4331676A2 (fr) | 2024-03-06 |
TW201809273A (zh) | 2018-03-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA52645A (fr) | Vaccins contre le virus respiratoire | |
MA50813A (fr) | Vaccins contre le virus d'epstein-barr | |
HK1255847A1 (zh) | 針對乙型肝炎病毒的疫苗 | |
MA50335A (fr) | Vaccins à acide nucléique contre des virus respiratoires | |
MA47787A (fr) | Vaccin contre le virus respiratoire syncytial | |
MA46317A (fr) | Vaccin contre le virus respiratoire syncytial | |
SG10201913630YA (en) | Zika virus vaccine | |
ZA201700165B (en) | Influenza virus vaccines and uses thereof | |
PL3393510T3 (pl) | Szczepionka przeciwko wirusowi zika | |
MA42502A (fr) | Vaccins contre une maladie infectieuse | |
MA46378A (fr) | Vaccins hpv16 thérapeutiques | |
CL2017000063A1 (es) | Vacunas contra virus influenza y usos de las mismas | |
GB201613191D0 (en) | Zika virus vaccine | |
SG11201702116VA (en) | Viral rna segments as immunomodulatory agents and vaccine components | |
SG11201701256RA (en) | Vaccine compositions against dengue virus diseases | |
IL263550A (en) | Infectious bronchitis virus vaccine | |
IL247185A0 (en) | Tilapia virus vaccines | |
MA45994A (fr) | Vaccins contre des virus | |
IL249704A0 (en) | Influenza virus vaccines and their uses | |
IL249705B (en) | Influenza virus vaccines and their uses | |
GB201702193D0 (en) | Hepatitis E virus vaccine | |
PT3393510T (pt) | Vacina contra o vírus zika | |
TH1501007185A (th) | ไวรัสและวัคซีน | |
TH1501007823A (th) | วิธีการเเละองค์ประกอบสำหรับวัคซีนเดงกีไวรัส |